These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37949699)

  • 1. Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
    Hamdy FC; Donovan JL
    Eur Urol; 2024 Feb; 85(2):e54-e55. PubMed ID: 37949699
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
    Hamdy FC; Donovan JL
    Eur Urol; 2024 Feb; 85(2):e41-e42. PubMed ID: 37659961
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023; 388:1547-58.
    Rocco B; Sighinolfi MC
    Eur Urol; 2024 Feb; 85(2):e40. PubMed ID: 37684177
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Freddie C. Hamdy, Jennie L. Donovan, J. Athene Lane, et al. Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
    Campodonico F
    Eur Urol Oncol; 2024 Feb; 7(1):171. PubMed ID: 37474401
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Brandon A. Mahal, Anthony V. D'Amico, and Paul L. Nguyen's Letter to the Editor re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96.
    Shore ND; Dearnaley D; Tombal B
    Eur Urol; 2020 Nov; 78(5):e196-e197. PubMed ID: 32838997
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. Hamdy et al. NEJM October 2016.
    Peters M; van der Voort van Zyp JRN; Verkooijen HM
    World J Urol; 2017 Sep; 35(9):1465. PubMed ID: 28210766
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study.
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):211. PubMed ID: 24445293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607-613.
    Shah N; Ioffe V
    J Urol; 2017 Aug; 198(2):445-446. PubMed ID: 28457843
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Van Poppel H; Roobol MJ
    Eur Urol; 2022 Jan; 81(1):e23-e24. PubMed ID: 34756628
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.
    Kerkmeijer LGW; Pos FJ; van der Heide UA; Israël B; Draulans C; Haustermans K
    Eur Urol; 2022 Jun; 81(6):e147-e148. PubMed ID: 35339319
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
    Touijer K
    Eur Urol; 2018 Jul; 74(1):e18-e19. PubMed ID: 29691082
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Carsten Stephan, Henning Cammann, and Klaus Jung's Letter to the Editor re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
    Tomlins SA; Groskopf J; Chinnaiyan AM
    Eur Urol; 2015 Nov; 68(5):e108. PubMed ID: 26242717
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.
    Burns JA; Weiner AB; Kundu S
    Eur Urol; 2019 Oct; 76(4):e99-e100. PubMed ID: 31151679
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Yuxuan Song, Yiqing Du, and Tao Xu's Letter to the Editor re: Matthew Mossanen, Filipe L.F. Carvalho, Vinayak Muralidhar, et al. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. Eur Urol 2022;81:466-73.
    Carvalho FLF; Mossanen M; Van Allen EM; Mouw KW
    Eur Urol; 2022 Nov; 82(5):e141-e142. PubMed ID: 35945087
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on: "Long-term functional outcomes after treatment for localized prostate cancer." Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, Nashville, TN.: N Engl J Med 2013;368(5):436-45. doi: 10.1056/NEJMoa1209978.
    Eggener S
    Urol Oncol; 2014 May; 32(4):513-4. PubMed ID: 24767688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to Roderick C.N. van den Bergh, Massimo Valerio, Derya Tilki, and Giorgio Gandaglia's Letter to the Editor re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.02.009.
    Wilt TJ; Dahm P; Brawer MK
    Eur Urol; 2020 Aug; 78(2):e69-e70. PubMed ID: 32303386
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Wei Wang and Guowei Shi's Letter to the Editor re: Mathew D. Sorensen, Jonathan D. Harper, Michael S. Borofsky, et al. Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse. N Engl J Med 2022;387:506-13.
    Sorensen MD; Bailey MR; Harper JD
    Eur Urol; 2023 Mar; 83(3):e80-e81. PubMed ID: 36526490
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8.
    Ennis RD; Hu L; Ryemon SN; Lin J; Mazumdar M
    Eur Urol Oncol; 2019 Mar; 2(2):226-227. PubMed ID: 31017102
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    Chang D; Appu S; Siva S
    Eur Urol; 2023 Oct; 84(4):436-437. PubMed ID: 37268486
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    Cooperberg MR
    Eur Urol; 2023 Oct; 84(4):435-436. PubMed ID: 37208238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.